World's Best Scientists 2026 revealed!
Antonio Arnaiz-Villena

Antonio Arnaiz-Villena

Antonio Arnaiz-Villena publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Antonio Arnaiz-Villena sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

The last bar groups every scientist with 807 publications or more.

Antonio Arnaiz-Villena D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Antonio Arnaiz-Villena sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

The last bar groups every scientist with 157 D-Index or more.

Overview

Antonio Arnaiz-Villena is affiliated with the Complutense University of Madrid in Spain, contributing extensively to research in immunology, microbiology, and related fields. Their body of work spans multiple disciplines including immunology, archaeology, molecular biology, agronomy and crop science, and linguistics.

The primary fields of study focus on immunology and microbiology, with 37 publications, and arts and humanities, accounting for 30 publications. Specific subfields in which they have published include immunology (35 publications), archeology (25 publications), molecular biology (8 publications), agronomy and crop science (5 publications), and language and linguistics (4 publications).

Their research encompasses a variety of topics, including:

  • T-cell and B-cell Immunology
  • Archaeological and Historical Studies
  • Archaeological and Geological Studies
  • Vaccines and Immunoinformatics Approaches
  • Reproductive System and Pregnancy
  • Immune Cell Function and Interaction
  • Reproductive Physiology in Livestock

Antonio Arnaiz-Villena has authored and co-authored a range of papers notable for their focus on immunogenetics and molecular interactions related to human leukocyte antigen (HLA) genes. Recent publications include:

  • "HLA-G: Too Much or Too Little? Role in Cancer and Autoimmune Disease" (2022) published in Frontiers in Immunology
  • "HLA-G: Function, polymorphisms and pathology" (2020) published in International Journal of Immunogenetics
  • "Evolution and molecular interactions of major histocompatibility complex (MHC)-G, -E and -F genes" (2022) published in Cellular and Molecular Life Sciences
  • "HLA-G 3'UTR Polymorphisms Are Linked to Susceptibility and Survival in Spanish Gastric Adenocarcinoma Patients" (2021) published in Frontiers in Immunology
  • "The Iberian-Guanche rock inscriptions at La Palma Is.: all seven Canary Islands (Spain) harbour these scripts" (2020) published in International Journal of Modern Anthropology

Frequently collaborating colleagues include Fabio Suárez-Trujillo, Ignacio Juárez, Adrián López-Nares, José Manuel Martín-Villa, and Christian Vaquero-Yuste. These co-authors have contributed extensively alongside Arnaiz-Villena, indicating repeated partnerships within immunology and related topics.

Antonio Arnaiz-Villena's research has appeared regularly in several academic venues, reflecting the interdisciplinary nature of their work. The most frequent publication venues comprise:

  • International Journal of Modern Anthropology (12 publications)
  • Human Immunology (12 publications)
  • Frontiers in Immunology (3 publications)
  • International Journal of Immunogenetics (2 publications)
  • Scientific Reports (2 publications)

Best Publications

  • Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association

    Eduardo A. Donadi;Erick C. Castelli;Antonio Arnaiz-Villena;Michel Roger

  • Brief report: primary immunodeficiency caused by mutations in the gene encoding the CD3-gamma subunit of the T-lymphocyte receptor.

    Arnaiz-Villena A;Timon M;Corell A;Perez-Aciego P

  • HLA allele and haplotype frequencies in Algerians: Relatedness to Spaniards and Basques

    Antonio Arnaiz-Villena;Djamal Benmamar;Miguel Alvarez;Nieves Diaz-Campos

  • Relatedness among Basques, Portuguese, Spaniards, and Algerians studied by HLA allelic frequencies and haplotypes.

    A. Arnaiz-Villena;Jorge Martínez-Laso;Eduardo Gómez-Casado;Nieves Díaz-Campos

  • HLA genes in Macedonians and the sub-Saharan origin of the Greeks.

    A. Arnaiz-Villena;K. Dimitroski;A. Pacho;J. Moscoso

  • The contribution of the HLA‐A, ‐B, ‐C and ‐DR, ‐DQ DNA typing to the study of the origins of Spaniards and Basques

    J Martinez-Laso;D De Juan;N Martinez-Quiles;E Gomez-Casado

  • THE ORIGIN OF CRETAN POPULATIONS AS DETERMINED BY CHARACTERIZATION OF HLA ALLELES

    A. Arnaiz‐Villena;P. Iliakis;M. González‐Hevilla;J. Longás

  • HLA genes in Mexican Mazatecans, the peopling of the Americas and the uniqueness of Amerindians.

    A. Arnaiz-Villena;G. Vargas-Alarcón;J. Granados;E. Gómez-Casado

  • Familial defect in the surface expression of the T-cell receptor-CD3 complex.

    Balbino Alarcon;Jose Ramon Regueiro;Antonio Arnaiz-Villena;Cox Terhorst

  • HLA alleles and haplotypes in the Turkish population: relatedness to Kurds, Armenians and other Mediterraneans.

    A. Arnaiz-Villena;M. Karin;N. Bendikuze;E. Gomez-Casado

  • Population genetic relationships between Mediterranean populations determined by HLA allele distribution and a historic perspective

    A. Arnaiz‐Villena;E. Gomez‐Casado;J. Martinez‐Laso

  • A new HLA-G allele (HLA-G*0105N) and its distribution in the Spanish population.

    M. B. Suárez;P. Morales;M. José Castro;Víctor Fernández

  • Three new HLA-G alleles and their linkage disequilibria with HLA-A

    Morales P;Corell A;Martínez-Laso J;Martín-Villa Jm

  • The Fourth International Serum Exchange Workshop to standardize cytoplasmic islet cell antibodies

    Å Lernmark;J. L. Molenaar;W. A. M. van Beers;Y. Yamaguchi

  • The Fourth International Workshop on the Standardisation of Insulin Autoantibody Measurement

    H. Kolb;A. Arnaiz-Villena;C. E. de Beaufort;D. Becker

  • HLA class I and class II haplotypes in admixed families from several regions of Mexico.

    Rodrigo Barquera;Joaquín Zúñiga;Raquel Hernández-Díaz;Victor Acuña-Alonzo

  • Killer immunoglobulin receptor gene and allele frequencies in Caucasoid, Oriental and Black populations from different continents.

    D Middleton;D Middleton;A Meenagh;J Moscoso;A Arnaiz-Villena

  • Homozygous HLA-G*0105N healthy individuals indicate that membrane-anchored HLA-G1 molecule is not necessary for survival.

    M.J. Castro;P. Morales;R. Rojo-Amigo;J. Martinez-Laso

  • HLA antigens in a sample of the Spanish population: Common features among Spaniards, Basques, and Sardinians

    A. Arnaiz-Villena;S. Rodriguez de Córdoba;F. Vela;J. C. Pascual

  • HLA-DR3, DR4 increase in chronic stage of Spanish oil disease.

    J.L. Vicario;M. Serrano-Rios;F. San Andrés;A. Arnaiz-Villena

Frequent Co-Authors

Julio Granados
Julio Granados Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
José Alcamí
José Alcamí Instituto de Salud Carlos III
Jukka Partanen
Jukka Partanen Finnish Red Cross
Derek Middleton
Derek Middleton University of Liverpool
Cox Terhorst
Cox Terhorst Beth Israel Deaconess Medical Center
Roger L. Dawkins
Roger L. Dawkins Murdoch University
Margarita López-Trascasa
Margarita López-Trascasa Autonomous University of Madrid
Miguel López-Botet
Miguel López-Botet Pompeu Fabra University
Michael Wink
Michael Wink Heidelberg University
Marc Busson
Marc Busson Grenoble Alpes University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology with a healthcare focus, pursuing nursing degrees offers valuable pathways. Many students start with an accelerated BSN programs for non nurses, which provide a fast track into nursing for individuals without a prior healthcare background. These programs are designed to equip students with core nursing skills efficiently, making them ideal for career changers.

Building on an initial nursing degree, accelerated nurse practitioner programs are an excellent option for specialization. You can explore accelerated NP programs online that offer flexibility and advanced clinical training necessary for roles in immunology-related care settings.

For nurses aiming to expand their expertise, transitioning through an fnp to acute care np bridge program is a strategic move. These programs help nurse practitioners gain acute care specialization, often relevant in immunology-focused clinical environments.

Additionally, those without any nursing prerequisites can start through online accelerated nursing programs for non nurses. These degree options provide accessible routes to enter the nursing profession and eventually pursue advanced practice roles connected to immunology research and patient care.

Best Scientists Citing Antonio Arnaiz-Villena

Trending Scientists

Recently Published Articles